Abstract
Quinupristin-dalfopristin is a streptogramin combination active against multiply resistantEnterococcus faecium. Among 45E. faeciumisolated from patients in various French hospitals, only two strains were intermediate (MIC = 2 μg/ml) and one,E. faeciumHM1032, was resistant (MIC = 16 μg/ml) to quinupristin-dalfopristin, according to British Society for Antimicrobial Chemotherapy and National Committee for Clinical Laboratory Standards approved breakpoints. The latter strain contained thevgbandsatAgenes responsible for hydrolysis or acetylation of quinupristin and dalfopristin, respectively, and anermBgene (also previously referred to asermAM) encoding a ribosomal methylase. The two intermediate strains had an LSAphenotype characterized by resistance to lincomycin (L), increased MICs (≥8 μg/ml) of dalfopristin (streptogramin A [SA]), and susceptibility to erythromycin and quinupristin. This phenotype was also detected in eight other strains susceptible to quinupristin-dalfopristin. No genes already known and conferring resistance to dalfopristin by acetylation or active efflux were detected in these LSAstrains. Nineteen other strains resistant to erythromycin but susceptible to the quinupristin-dalfopristin combination displayed elevated MICs of quinupristin after induction (from 16 to >128 μg/ml) and containedermBgenes. The effects ofermB,vgb, andsatAgenes on the activity of the streptogramin combination were tested by cloning these genes individually or in various combinations in recipient strains susceptible to quinupristin-dalfopristin,E. faeciumHM1070 andStaphylococcus aureusRN4220. The presence of both thesatAandvgbgenes (regardless of the presence of anermBgene) was necessary to confer full quinupristin-dalfopristin resistance to the host. The same genetic constructs were introduced intoE. faeciumBM4107 which displays a LSAphenotype. Addition of thesatAorvgbgene to this LSAbackground conferred resistance to quinupristin-dalfopristin.

This publication has 37 references indexed in Scilit: